Key facts
- Prolucent’s last known valuation is $42.0M.
- It has raised $16.7M; the latest was Later Stage VC ($4.0M) in Oct 2024.
- Notable investors include A1 Health Ventures, Abundant Venture Partners, Fitzroy Health, Health Velocity Capital, Northwell Holdings — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Prolucent
- ·The full record, as it builds
Funding rounds
No funding rounds for Prolucent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prolucent
Provider of healthcare workforce services intended to align labor needs with data-driven decision-making. The company's platform uses artificial intelligence and advanced analytics to modernize and improve the recruitment, utilization, and cost of healthcare labor, enabling employers to manage the quality and cost of their workforce from full-time recruitment to contingent workforce management while engaging healthcare workers to find opportunities.
- Sector
- Business Products and Services (B2B)
- HQ
- Dallas, TX, United States
- Founded
- 2019
- Employees
- 58
- Website
- prolucent.com/
- Ownership
- Privately Held (backing)
Prolucent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prolucent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prolucent in its N-PORT filings yet. We sweep new filings monthly.